The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in ...

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

The tech-heavy Nasdaq Composite rallied more than 9% this month. Information technology stocks are the top-performing sector ...

Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Humana, (NYSE:HUM) listed on the NYSE and a constituent of the Russell 1000, operates within the health care sector.

This handy guide will help you understand some of the jargon in corporate earnings reports and why it is important for ...

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

“Our team has done a great job launching us on a strong start to the year,” Humana president and chief executive officer Jim Rechtin said in a statement accompanying the earnings report.

Humana (HUM) came out with quarterly earnings of $11.58 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $7.23 per share a year ago. These figures are ...

Humana HUM is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement. Analysts estimate that Humana will report an ...

Is Humana a buy or sell going into earnings? Read our full analysis here ... Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.